Psychotic Disorders - Indonesia | Statista Market Forecast

Revenue in the Psychotic Disorders market is projected to reach US$86.80m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of -0.59%, resulting in a market volume of US$84.29m by 2029.
In global comparison, most revenue will be generated United States (US$2.26bn in 2024).
In relation to total population figures, per person revenues of US$47.52 are generated in 2024.

Psychotic disorders are severe mental health disorders that cause changes in a person's way of thinking and their perception. Patients often have trouble differentiating between what they perceive and reality. Different types of psychotic disorders include schizophrenia, bipolar disorder, substance-induced psychotic disorder, delusional disorder, and brief psychotic disorder. However, this market only represents the sales of antipsychotic drugs that are used to treat schizophrenia and bipolar disorder.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Otsuka Pharmaceutical, Lundbeck, AbbVie, Allergan plc, Recordati S.p.A., Gadeon Richter, Sumitomo Pharma, Johnson & Johnson / Janssen, Vanda Pharmaceuticals, Alkermes, Eli Lilly, AstraZeneca, and Intra-Cellular Therapies

Antipsychotic drugs: Aripiprazole (Abilify), Asenapine (Saphris), Cariprazine (Vraylar), Clozapine (Clozaril, Versacloz), lumateperone (Caplyta), Lurasidone (Latuda), Olanzapine (Zyprexa), Quetiapine (Seroquel), Risperidone (Risperdal), Risperidone (Aristada), Ziprasidone (Geodon), Brexpiprazole (Rexulti), Iloperidone (Fanapt), and Paliperidone (Invega)

Psychotherapy
Talk therapy
Herbal medicines
Digital health apps
Deep Brain Stimulation (DBS)

The Psychotic Disorders market in Indonesia is experiencing significant growth and development.

Customer preferences: In Indonesia, there is a growing demand for effective treatments and therapies for psychotic disorders. Customers are increasingly seeking out medications and therapies that can help manage symptoms and improve quality of life. They are also becoming more aware of the importance of early intervention and are seeking out healthcare professionals who can provide accurate diagnoses and appropriate treatment plans.

Trends in the market: One major trend in the Psychotic Disorders market in Indonesia is the increasing availability and accessibility of mental health services. There has been a push from the government and healthcare organizations to improve mental health services and increase the number of healthcare professionals specializing in mental health. This has led to more clinics and hospitals offering specialized services for psychotic disorders, as well as an increase in the number of psychiatrists and psychologists practicing in the country.Another trend in the market is the development of new and innovative treatment options. Pharmaceutical companies are investing in research and development to create more effective medications with fewer side effects. Additionally, there is a growing interest in non-pharmacological treatments such as cognitive-behavioral therapy and psychosocial interventions. These alternative treatments are gaining popularity as they can be used in conjunction with medication or as standalone therapies.

Local special circumstances: Indonesia has a large population, and the prevalence of psychotic disorders is relatively high. This has created a significant market for treatments and therapies for these conditions. Additionally, there is a growing awareness and acceptance of mental health issues in the country. This has led to a decrease in the stigma surrounding mental health and an increase in the number of individuals seeking help for psychotic disorders.

Underlying macroeconomic factors: The Indonesian economy has been growing steadily in recent years, which has contributed to an increase in healthcare spending. As the economy continues to grow, more individuals will have access to healthcare services, including those for psychotic disorders. Additionally, the government has been increasing its investment in healthcare infrastructure and services, which will further drive the growth of the Psychotic Disorders market.In conclusion, the Psychotic Disorders market in Indonesia is developing rapidly due to increasing customer preferences for effective treatments, the availability of mental health services, the development of new treatment options, the high prevalence of psychotic disorders in the country, and the underlying macroeconomic factors such as economic growth and government investment in healthcare. As the market continues to grow, there will be more opportunities for healthcare providers and pharmaceutical companies to meet the demand for treatments and therapies for psychotic disorders.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.